China's Innovent Biologics hits all-time high on higher H1 results

Innovent Biologics

26/08/2026 03:47

** Shares of China's Innovent Biologics 1801.HK jump 12.6% to HK$112.7, their all-time high since trading debut in October 2018
** Stock set for the biggest one-day pct gain since June 4, 2025
** Innovative medicines developer and producer says its H1 revenue rose 44.8% y/y, net profit up 50.2% y/y
** Company expects continued revenue and profit growth as new products and indications are approved
** Nomura, with "Buy" rating on the stock, says Innovent's 1H26 earnings beat driven by higher product sales 
** YTD, stock up 43.6%, Hang Seng Biotech Index .HSBIO up 15.2%
     

 (Reporting by Donny Kwok)
 ((donny.kwok@thomsonreuters.com))